Related Experiment Video
Updated: Aug 25, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin therapy
1Departmrnt of Neurology, University of Buffalo School of Medicine, 311 Biomedical Research Building, Buffalo, NY 14214, USA.
Abstract:
There is a need for alternative therapies for hot flashes, as hormone replacement therapy (HRT) is associated with increased rates of breast cancer and heart disease, and some women fail to respond to HRT. A 32-year-old woman with surgically-induced menopause experienced 20-30 severe hot flashes per day and failed to respond to various formulations of HRT and selective serotonin reuptake inhibitor (SSRI) therapy for 17 years. She markedly responded to gabapentin therapy. Gabapentin, SSRIs, and estrogen may act at different cellular targets in the treatment of hot flashes.
Related Concept Videos
Menopause
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Increased Body Temperature
Antidepressant Drugs: MAOIs and Other Agents
Decreased Body Temperature
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
